These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24224851)

  • 21. Genetic polymorphism of XRCC1 Arg399Gln is associated with survival in non-small-cell lung cancer patients treated with gemcitabine/platinum.
    Liao WY; Shih JY; Chang GC; Cheng YK; Yang JC; Chen YM; Yu CJ
    J Thorac Oncol; 2012 Jun; 7(6):973-81. PubMed ID: 22551904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between X-ray repair cross-complementation group 1 rs25487 polymorphism and pancreatic cancer risk.
    Jiang H; Wu D; Ma D; Lin G; Liang J; Jin J
    Tumour Biol; 2013 Dec; 34(6):3417-21. PubMed ID: 23807675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and cervical cancer risk: a huge systematic review and meta-analysis.
    Li Y; Liu F; Tan SQ; Wang Y; Li SW
    PLoS One; 2012; 7(9):e44441. PubMed ID: 22984511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. XRCC1 genetic polymorphism Arg399Gln and gastric cancer risk: A meta-analysis.
    Geng J; Zhang YW; Huang GC; Chen LB
    World J Gastroenterol; 2008 Nov; 14(43):6733-7. PubMed ID: 19034980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Association Between the XRCC1 Arg399Gln Polymorphism and the Risk of Head and Neck Cancer: An Updated Meta-Analysis Including 14586 Subjects.
    Xia S; Wu S; Wang M
    Technol Cancer Res Treat; 2021; 20():15330338211033060. PubMed ID: 34278875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influences of ERCC1, ERCC2, XRCC1, GSTP1, GSTT1, and MTHFR polymorphisms on clinical outcomes in gastric cancer patients treated with EOF chemotherapy.
    Liu R; Zhao X; Liu X; Chen Z; Qiu L; Geng R; Guo W; He G; Yin J; Li J; Zhu X
    Tumour Biol; 2016 Feb; 37(2):1753-62. PubMed ID: 26314858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymorphisms in p53, GSTP1 and XRCC1 predict relapse and survival of gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy.
    Huang ZH; Hua D; Du X
    Cancer Chemother Pharmacol; 2009 Oct; 64(5):1001-7. PubMed ID: 19247656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between X-ray repair cross-complementing group 1(XRCC1) Arg399Gln polymorphism and endometriosis: A systematic review and meta-analysis.
    Lv MQ; Wang J; Yu XQ; Hong HH; Ren WJ; Ge P; Zhou DX
    Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():12-20. PubMed ID: 28926725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of the association between XRCC1 Arg399Gln polymorphism and lung cancer in Chinese.
    Li Y; Huang Y; Cao YS; Zeng J; Tong WN; Xu SL; Zhuo AS
    Tumour Biol; 2013 Dec; 34(6):3681-5. PubMed ID: 23884604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphisms of XRCC1 and risk of esophageal and gastric cardia cancer.
    Ratnasinghe LD; Abnet C; Qiao YL; Modali R; Stolzenberg-Solomon R; Dong ZW; Dawsey SM; Mark SD; Taylor PR
    Cancer Lett; 2004 Dec; 216(2):157-64. PubMed ID: 15533591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An updated meta-analysis between the association of XRCC1 Arg399Gln polymorphism and hepatocellular carcinoma risk.
    Zhang XL; Lu Y; Yang S; Peng QL; Wang J; Xie L; Deng Y; He Y; Li TJ; Qin X; Li S
    Asian Pac J Cancer Prev; 2014; 15(7):3273-8. PubMed ID: 24815482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and gastric cancer risk: A HuGE review and meta-analysis.
    Xue H; Ni P; Lin B; Xu H; Huang G
    Am J Epidemiol; 2011 Feb; 173(4):363-75. PubMed ID: 21216841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic polymorphism of XRCC1 correlated with response to oxaliplatin-based chemotherapy in advanced colorectal cancer.
    Lv H; Li Q; Qiu W; Xiang J; Wei H; Liang H; Sui A; Liang J
    Cancer Invest; 2013 Jan; 31(1):24-8. PubMed ID: 23327191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BRCA1 and XRCC1 polymorphisms associated with survival in advanced gastric cancer treated with taxane and cisplatin.
    Shim HJ; Yun JY; Hwang JE; Bae WK; Cho SH; Lee JH; Kim HN; Shin MH; Kweon SS; Lee JH; Kim HJ; Chung IJ
    Cancer Sci; 2010 May; 101(5):1247-54. PubMed ID: 20331623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymorphism of XRCC1 predicts overall survival of gastric cancer patients receiving oxaliplatin-based chemotherapy in Chinese population.
    Liu B; Wei J; Zou Z; Qian X; Nakamura T; Zhang W; Ding Y; Feng J; Yu L
    Eur J Hum Genet; 2007 Oct; 15(10):1049-53. PubMed ID: 17593927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of XRCC1 gene polymorphisms with the survival and clinicopathological characteristics of gastric cancer.
    Zhang Y; Wang M; Gu D; Wu D; Zhang X; Gong W; Tan Y; Zhou J; Wu X; Tang C; Zhang Z; Chen J
    DNA Cell Biol; 2013 Mar; 32(3):111-8. PubMed ID: 23425027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. XRCC1 and XPD genetic polymorphisms and susceptibility to age-related cataract: a meta-analysis.
    Chi XX; Liu YY; Shi SN; Cong Z; Liang YQ; Zhang HJ
    Mol Vis; 2015; 21():335-46. PubMed ID: 25873778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. X-ray repair cross-complementing group 1(XRCC1) genetic polymorphisms and thyroid carcinoma risk: a meta-analysis.
    Qian K; Liu KJ; Xu F; Chen XY; Chen GN; Yi WJ; Zhou EX; Tang ZH
    Asian Pac J Cancer Prev; 2012; 13(12):6385-90. PubMed ID: 23464463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene polymorphism of XRCC1 Arg399Gln and cervical carcinoma susceptibility in Asians: a meta-analysis based on 1,759 cases and 2,497 controls.
    Liu YT; Shi JP; Fu LY; Zhou B; Wang HL; Wu XM
    Asian Pac J Cancer Prev; 2013; 14(1):189-93. PubMed ID: 23534722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship between five non-synonymous polymorphisms within three XRCC genes and gastric cancer risk in a Han Chinese population.
    Gong H; Li H; Zou J; Mi J; Liu F; Wang D; Yan D; Wang B; Zhang S; Tian G
    Tumour Biol; 2016 May; 37(5):5905-10. PubMed ID: 26590607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.